Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 418

Results For "ABLE"

5258 News Found

Jean-Luc Herbeaux to become Hovione CEO
People | February 26, 2022

Jean-Luc Herbeaux to become Hovione CEO

Guy Villax was also involved with the EFCG and Rx-360 associations and contributed to legislation being passed on both sides of the Atlantic to fight fake medicines and to level the playing field for GMP manufacturing.


Japan approves Keytruda plus Lenvima for two types of cancer
Drug Approval | February 26, 2022

Japan approves Keytruda plus Lenvima for two types of cancer

Keytruda plus Lenvima is also approved in the U.S. and Europe for the first-line treatment of adult patients with advanced RCC.


Wockhardt Hospitals, Mira Road opens centre for sports medicine
Hospitals | February 25, 2022

Wockhardt Hospitals, Mira Road opens centre for sports medicine

The facility is spread across 215000 sq. feet and provides super-speciality care


Mandaviya launches ICMR/ DHR policy on biomedical innovation & entrepreneurship
Policy | February 25, 2022

Mandaviya launches ICMR/ DHR policy on biomedical innovation & entrepreneurship

This policy will ensure multi-disciplinary collaboration, promote start-up culture and develop an innovation-led ecosystem at medical institutes across the country


Actu-Real and Jehangir Clinical Dev Centre announce strategic collaboration
Biotech | February 25, 2022

Actu-Real and Jehangir Clinical Dev Centre announce strategic collaboration

The joint initiative is called J-ARC Healthcare Solutions


Canada approves plant-based Covid-19 vaccine
News | February 25, 2022

Canada approves plant-based Covid-19 vaccine

Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine


Risk appetite key to innovation in pharma and biopharma
News | February 25, 2022

Risk appetite key to innovation in pharma and biopharma

Industry leaders discusses the need of innovation for the Indian drug industry at BioAsia 2022.


GliaPharm SA collaborate with Wyss Centre for Alzheimer therapy
Biotech | February 25, 2022

GliaPharm SA collaborate with Wyss Centre for Alzheimer therapy

The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers


UK Vaccine Network funding for ConserV pan-coronavirus project
News | February 25, 2022

UK Vaccine Network funding for ConserV pan-coronavirus project

UNICOR-v has the potential to protect against future epidemics caused by a coronavirus jumping from animals to humans, but also against new variants emerging from SARS-Cov-2


Experts say extended day prescription refills for hypertension can be a game-changer
Healthcare | February 24, 2022

Experts say extended day prescription refills for hypertension can be a game-changer

The recently released WHO guideline on hypertension treatment (2021), recommends that patients with stable blood pressure can be asked to visit clinics at 3-6 month intervals as an important strategy to improve hypertension control